Sensing the immune microenvironment to coordinate T cell metabolism, differentiation & function

Seminars in Immunology

Volumn 24, Issue 6, 2012, Pages 414-420

  Heikamp, Emily B ^a   Powell, Jonathan D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

CD4; CD8 T cells; Metabolism; MTOR

Indexed keywords

GLUTAMINE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL METABOLISM; CELL MIGRATION; CHOLESTEROL SYNTHESIS; GLYCOLYSIS; HUMAN; IMMUNE RESPONSE; LIPOGENESIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MICROENVIRONMENT; MITOCHONDRION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; MICE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOR SERINE-THREONINE KINASES;

EID: 84874257493     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2012.12.003     Document Type: Review

References (76)

1. Rathmell J.C. T cell myc-tabolism. Immunity 2011, 35:845-846.
2. Fox C.J., Hammerman P.S., Thompson C.B. Fuel feeds function: energy metabolism and the T-cell response. Nature Reviews Immunology 2005, 5:844-852.
3. Bauer D.E., Harris M.H., Plas D.R., Lum J.J., Hammerman P.S., Rathmell J.C., et al. Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand. FASEB Journal 2004, 18:1303-1305.
4. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
5. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nature Reviews Cancer 2011, 11:85-95.
6. Gillies R.J., Robey I., Gatenby R.A. Causes and consequences of increased glucose metabolism of cancers. Journal of Nuclear Medicine 2008, 49(Suppl. 2):24S-42S.
7. Wang R., Dillon C.P., Shi L.Z., Milasta S., Carter R., Finkelstein D., et al. The transcription factor myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 2011, 35:871-882.
8. van der Windt G.J., Everts B., Chang C.H., Curtis J.D., Freitas T.C., Amiel E., et al. Mitochondrial respiratory capacity is a critical regulator of CD8(+) T cell memory development. Immunity 2011.
9. Frauwirth K.A., Riley J.L., Harris M.H., Parry R.V., Rathmell J.C., Plas D.R., et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002, 16:769-777.
10. Frauwirth K.A., Thompson C.B. Regulation of T lymphocyte metabolism. Journal of Immunology 2004, 172:4661-4665.
11. Laplante M., Sabatini D.M. mTOR signaling at a glance. Journal of Cell Science 2009, 122:3589-3594.
12. Dann S.G., Thomas G. The amino acid sensitive TOR pathway from yeast to mammals. FEBS Letters 2006, 580:2821-2829.
13. Zoncu R., Efeyan A., Sabatini D.M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Reviews Molecular Cell Biology 2011, 12:21-35.
14. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
15. Waickman A.T., Powell J.D. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunological Reviews 2012, 249:43-58.
16. Yecies J.L., Manning B.D. Transcriptional control of cellular metabolism by mTOR signaling. Cancer Research 2011, 71:2815-2820.
17. Wang L., Harris T.E., Roth R.A., Lawrence J.C. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. Journal of Biological Chemistry 2007, 282:20036-20044.
18. Yamagata K., Sanders L.K., Kaufmann W.E., Yee W., Barnes C.A., Nathans D., et al. Rheb: a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. Journal of Biological Chemistry 1994, 269:16333-16339.
19. Zhang Y., Gao X., Saucedo L.J., Ru B., Edgar B.A., Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nature Cell Biology 2003, 5(6):578-581.
20. Peterson T.R., Laplante M., Thoreen C.C., Sancak Y., Kang S.A., Kuehl W.M., et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 2009, 137:873-886.
21. Corradetti M.N., Inoki K., Bardeesy N., DePinho R.A., Guan K.L. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes and Development 2004, 18:1533-1538.
22. Lee M., Hwang J.T., Lee H.J., Jung S.N., Kang I., Chi S.G., et al. AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. Journal of Biological Chemistry 2003, 278:39653-39661.
23. Sengupta S., Peterson T.R., Sabatini D.M. Regulation of the mTOR complex 1 pathway by nutrients: growth factors, and stress. Molecular Cell 2010, 40:310-322.
24. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Molecular Cell 2008, 30:214-226.
25. Schneider A., Younis R.H., Gutkind J.S. Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma. Neoplasia 2008, 10:1295-1302.
26. Sancak Y., Peterson T.R., Shaul Y.D., Lindquist R.A., Thoreen C.C., Bar-Peled L., et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008, 320:1496-1501.
27. Kim E., Goraksha-Hicks P., Li L., Neufeld T.P., Guan K.L. Regulation of TORC1 by Rag GTPases in nutrient response. Nature Cell Biology 2008, 10:935-945.
28. Sancak Y., Bar-Peled L., Zoncu R., Markhard A.L., Nada S., Sabatini D.M. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290-303.
29. Zinzalla V., Stracka D., Oppliger W., Hall M.N. Activation of mTORC2 by association with the ribosome. Cell 2011, 144:757-768.
30. Chen C.H., Shaikenov T., Peterson T.R., Aimbetov R., Bissenbaev A.K., Lee S.W., et al. ER stress inhibits mTORC2 and Akt signaling through GSK-3beta-mediated phosphorylation of rictor. Sci Signal 2011, 4:ra10.
31. Guertin D.A., Stevens D.M., Thoreen C.C., Burds A.A., Kalaany N.Y., Moffat J., et al. Ablation in mice of the mTORC components raptor: rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Developmental Cell 2006, 11:859-871.
32. Ikenoue T., Inoki K., Yang Q., Zhou X., Guan K.L. Essential function of TORC2 in PKC and Akt turn motif phosphorylation: maturation and signalling. EMBO Journal 2008, 27:1919-1931.
33. Garcia-Martinez J.M., Alessi D.R. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochemical Journal 2008, 416:375-385.
34. Yang K., Neale G., Green D.R., He W., Chi H. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nature Immunology 2011, 12:888-897.
35. O'Brien T.F., Gorentla B.K., Xie D., Srivatsan S., McLeod I.X., He Y.W., et al. Regulation of T-cell survival and mitochondrial homeostasis by TSC1. European Journal of Immunology 2011, 41:3361-3370.
36. Wu Q., Liu Y., Chen C., Ikenoue T., Qiao Y., Li C.S., et al. The tuberous sclerosis complex-mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. Journal of Immunology 2011, 187:1106-1112.
37. Buttgereit F., Brand M.D., Muller M. ConA induced changes in energy metabolism of rat thymocytes. Bioscience Reports 1992, 12:109-114.
38. Gordan J.D., Thompson C.B., Simon M.C. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 2007, 12:108-113.
39. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. Journal of Experimental Medicine 2011, 208:1367-1376.
40. Shi Y., Sharma A., Wu H., Lichtenstein A., Gera J. Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway. Journal of Biological Chemistry 2005, 280:10964-10973.
41. Vartanian R., Masri J., Martin J., Cloninger C., Holmes B., Artinian N., et al. AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation. Molecular Cancer Research 2011, 9:115-130.
42. Duvel K., Yecies J.L., Menon S., Raman P., Lipovsky A.I., Souza A.L., et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Molecular Cell 2010, 39:171-183.
43. Brand K., Aichinger S., Forster S., Kupper S., Neumann B., Nurnberg W., et al. Cell-cycle-related metabolic and enzymatic events in proliferating rat thymocytes. European Journal of Biochemistry 1988, 172:695-702.
44. Zha X., Wang F., Wang Y., He S., Jing Y., Wu X., et al. Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Research 2011, 71:13-18.
45. Carr E.L., Kelman A., Wu G.S., Gopaul R., Senkevitch E., Aghvanyan A., et al. Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. Journal of Immunology 2010, 185:1037-1044.
46. Thomas T., Thomas T.J. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cellular and Molecular Life Sciences 2001, 58:244-258.
47. Wise D.R., DeBerardinis R.J., Mancuso A., Sayed N., Zhang X.Y., Pfeiffer H.K., et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:18782-18787.
48. Gao P., Tchernyshyov I., Chang T.C., Lee Y.S., Kita K., Ochi T., et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009, 458:762-765.
49. Porstmann T., Santos C.R., Griffiths B., Cully M., Wu M., Leevers S., et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 2008, 8:224-236.
50. Yecies J.L., Zhang H.H., Menon S., Liu S., Yecies D., Lipovsky A.I., et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab 2011, 14:21-32.
51. Schieke S.M., Phillips D., McCoy J.P., Aponte A.M., Shen R.F., Balaban R.S., et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. Journal of Biological Chemistry 2006, 281:27643-27652.
52. Cunningham J.T., Rodgers J.T., Arlow D.H., Vazquez F., Mootha V.K., Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007, 450:736-740.
53. Ramanathan A., Schreiber S.L. Direct control of mitochondrial function by mTOR. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:22229-22232.
54. Vander Heiden M.G., Li X.X., Gottleib E., Hill R.B., Thompson C.B., Colombini M. Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane. Journal of Biological Chemistry 2001, 276:19414-19419.
55. Michalek R.D., Gerriets V.A., Jacobs S.R., Macintyre A.N., MacIver N.J., Mason E.F., et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. Journal of Immunology 2011, 186(6):3299-3303.
56. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992, 68:879-887.
57. Procaccini C., De Rosa V., Galgani M., Abanni L., Cali G., Porcellini A., et al. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 2010, 33:929-941.
58. Delgoffe G.M., Kole T.P., Zheng Y., Zarek P.E., Matthews K.L., Xiao B., et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 2009, 30:832-844.
59. Delgoffe G.M., Pollizzi K.N., Waickman A.T., Heikamp E., Meyers D.J., Horton M.R., et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nature Immunology 2011, 12:295-303.
60. Dang E.V., Barbi J., Yang H.Y., Jinasena D., Yu H., Zheng Y., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011, 146:772-784.
61. Brugarolas J., Lei K., Hurley R.L., Manning B.D., Reiling J.H., Hafen E., et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes and Development 2004, 18:2893-2904.
62. Semenza G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Science's STKE 2007, 2007:cm8.
63. Araki K., Turner A.P., Shaffer V.O., Gangappa S., Keller S.A., Bachmann M.F., et al. mTOR regulates memory CD8 T-cell differentiation. Nature 2009, 460:108-112.
64. Rao R.R., Li Q., Odunsi K., Shrikant P.A. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and eomesodermin. Immunity 2010, 32:67-78.
65. He S., Kato K., Jiang J., Wahl D.R., Mineishi S., Fisher E.M., et al. Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cells. PLoS One 2011, 6:e20107.
66. Pearce E.L., Walsh M.C., Cejas P.J., Harms G.M., Shen H., Wang L.S., et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009, 460:103-107.
67. Schluns K.S., Kieper W.C., Jameson S.C., Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8T cells in vivo. Nature Immunology 2000, 1:426-432.
68. Ku C.C., Murakami M., Sakamoto A., Kappler J., Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 2000, 288:675-678.
69. Finlay D., Cantrell D. Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration. Annals of the New York Academy of Sciences 2010, 1183:149-157.
70. Bai A., Hu H., Yeung M., Chen J. Kruppel-like factor 2 controls T cell trafficking by activating l-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. Journal of Immunology 2007, 178:7632-7639.
71. Sinclair L.V., Finlay D., Feijoo C., Cornish G.H., Gray A., Ager A., et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nature Immunology 2008, 9:513-521.
72. Carlson C.M., Endrizzi B.T., Wu J., Ding X., Weinreich M.A., Walsh E.R., et al. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 2006, 442:299-302.
73. Sebzda E., Zou Z., Lee J.S., Wang T., Kahn M.L. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nature Immunology 2008, 9:292-300.
74. Rena G., Prescott A.R., Guo S., Cohen P., Unterman T.G. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting. Biochemical Journal 2001, 354:605-612.
75. Brunet A., Kanai F., Stehn J., Xu J., Sarbassova D., Frangioni J.V., et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. Journal of Cell Biology 2002, 156:817-828.
76. Hedrick S.M. The cunning little vixen: Foxo and the cycle of life and death. Nature Immunology 2009, 10:1057-1063.